We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




BIT Analytical Expands Clinical Chemistry, Immunology, Molecular Offerings

By LabMedica International staff writers
Posted on 03 Jan 2011
BIT Analytical Instruments (Schwalbach, Germany) has acquired French original equipment manufacturer (OEM), diagnostics instruments firm, C2 Diagnostics (Montpellier, France). More...
The purchase price was not revealed.

The acquisition will enable BIT to offer a larger range of services and technologies in areas of clinical chemistry, immunology, and molecular diagnostics. BIT Companies provide a full, turnkey portfolio for in vitro diagnosis (IVD) market OEMs

C2 is a leader in contract development, design, manufacture, and support of custom instrumentation for the diagnostic equipment industry, with a specialty in hematology. The company specializes in developing OEM instruments and has delivered and sold more than 10,000 instruments to small and mid-size diagnostic labs worldwide. The company is currently focused on developing a new hematology instrument.

With expertise in mechanics, optics, software, electronics, fluidics, and chemistry, C2 Diagnostics (C2D) also holds several in vitro diagnostics (IVD) patents. The company has its own 929-m2 facility that is registered by the FDA as a contract manufacturer

C2D is currently focused on hematology application, which has an end-user segment with a growing market size. The company's product offering is a family of over 10 models of compact, easy to operate, robust, and cost efficient diagnostic instruments.

Related Links:

BIT Analytical Instrument
C2 Diagnostics




Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.